Form 4: Akebia Therapeutics SVP, Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Steven Keith Burke, SVP, Chief Medical Officer of Akebia Therapeutics, sold 7,144 shares of common stock at $1.83 per share to cover tax withholding obligations.
Summary
- Steven Keith Burke, the SVP, Chief Medical Officer of Akebia Therapeutics, Inc., sold 7,144 shares of common stock on March 3, 2025.
- The shares were sold at a price of $1.83 per share.
- The sale was executed automatically by the issuer to cover tax withholding obligations related to the vesting and settlement of restricted stock units granted on February 28, 2022.
- The sale was made pursuant to a Rule 10b5-1 trading plan adopted on November 17, 2023.
- Following the transaction, Burke beneficially owns 809,090 shares of Akebia Therapeutics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and executed under a pre-arranged trading plan.
Industry Context
This is a routine Form 4 filing related to an insider selling shares to cover tax obligations. It's a common practice and doesn't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 2022-02-28 | Date of grant of restricted stock units to the reporting person. |
| 2023-11-17 | Date the reporting person adopted a Rule 10b5-1 trading plan. |
| 2025-03-03 | Date of the stock sale transaction. |
| 2025-03-04 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.